Key facts
- Fin-x’s last known valuation is $7.7M (Mar 2023).
- It has raised $5.1M; the latest was Seed Round ($2.4M) in Apr 2025.
- Notable investors include Founders Fund, Bossa Invest, Headline, DOMO.VC, Atlantico Partners — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Fin-x
- ·The full record, as it builds
Funding rounds
No funding rounds for Fin-x are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fin-x
Developer of a healthcare billing management platform designed to generate transparency, visibility, and security in medical remuneration. The company's platform manages and calculates payments, automates the execution of tasks, digitizes negotiated rules, and organizes billing processes, enabling hospitals to reduce the number of disputes, optimize resources, and have an integrated and consensual view.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2018
- Employees
- 79
- Website
- finxapp.com.br/
- Ownership
- Privately Held (backing)
Fin-x doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fin-x shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fin-x in its N-PORT filings yet. We sweep new filings monthly.